Oct 25, 2023 / 02:30PM GMT
Unidentified Participant
Good day, ladies and gentlemen. Welcome to The Fall Foliage MicroCap Rodeo Virtual Conference. The next presenting company is Adial Pharmaceuticals. (Event Instructions)
I'd now like to turn the floor over to today's host, Cary Claiborne, CEO of Adial Pharmaceuticals. Sir, the floor is yours.
Cary Claiborne - Adial Pharmaceuticals, Inc. - CEO
Thank you so much. Good morning, everyone. Before I begin, I'll just remind you that Adial is a public company and this presentation will include forward-looking statements. So I encourage you to review our risk factors on file with the SEC.
Adial Pharmaceuticals is a clinical-stage biopharm company focused on treating addictions. Our lead focus is for the treatment of alcohol use disorder, also known as AUD. Alcohol use disorder is a large unmet public health need. In United States, there are over 30 million people estimated to suffer from alcohol use disorder. It is the leading cause of death of people aged 15 to 49. It contributes over 200 different diseases. And it cost the US economy
Adial Pharmaceuticals Inc at The Fall Foliage MicroCap Rodeo Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot